EXPE
72
3
MA
71
2
GS
62
3
DE
60
12
CVX
32
4
SNA
53
3
OKE
56
3
MTB
67
4
NRG
62
-13
EMN
42
2
FIS
67
2
UNH
23
2
BAX
50
2
VLO
45
3
DD
33
3
AIZ
56
6
VIX
27
-8
DGX
57
2
CSCO
72
3
HAL
34
5
EXPE
72
3
MA
71
2
GS
62
3
DE
60
12
CVX
32
4
SNA
53
3
OKE
56
3
MTB
67
4
NRG
62
-13
EMN
42
2
FIS
67
2
UNH
23
2
BAX
50
2
VLO
45
3
DD
33
3
AIZ
56
6
VIX
27
-8
DGX
57
2
CSCO
72
3
HAL
34
5
Financhill
Back

ProShares Ultra QQQ Vs. Akero Therapeutics Industry Stock Comparison

Buy
69

QLD
ProShares Ultra QQQ

Last Price:
$109.40
Seasonality Move:
9.59%
Buy
68

AKRO
Akero Therapeutics

Last Price:
$53.61
Seasonality Move:
26.74%
Buy
69
ProShares Ultra QQQ (QLD) is a Buy

Is ProShares Ultra QQQ a Buy, Sell or Hold?

  • The current ProShares Ultra QQQ [QLD] share price is $108.95. The Score for QLD is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • QLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QLD Stock Price Chart

What is ProShares Ultra QQQ's stock price today?

  • The ProShares Ultra QQQ share price today is $108.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QLD is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

QLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.03 Buy
Relative Strength Index (14 RSI): 66.4 Buy
Chaikin Money Flow: -194932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (96.29 - 107.87) Buy
Bollinger Bands (100): (87.1 - 111.92) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.09 Buy
Relative Strength Index (14 RSI): 70.44 Buy
Chaikin Money Flow: -1219058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.53 - 50.43) Buy
Bollinger Bands (100): (34.89 - 51.35) Buy

QLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.67 Buy
20-day SMA: 104.53 Buy
50-day SMA: 92.56 Buy
200-day SMA: 101.51 Buy
8-day EMA: 106.83 Buy
20-day EMA: 103.32 Buy
50-day EMA: 98.7 Buy
200-day EMA: 98.06 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.82 Buy
20-day SMA: 46 Buy
50-day SMA: 42.47 Buy
200-day SMA: 36.08 Buy
8-day EMA: 51.3 Buy
20-day EMA: 47.76 Buy
50-day EMA: 44.57 Buy
200-day EMA: 37.75 Buy

ProShares Ultra QQQ Earnings Growth & QLD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

ProShares Ultra QQQ Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):